Press Release

Printer Friendly Version View printer-friendly version
<< Back
Company Profile for POZEN Inc.

--(BUSINESS WIRE)--POZEN (NASDAQ: POZN) is a pharmaceutical company committed to developing therapeutic advancements for diseases with unmet medical needs where it can improve efficacy, safety, and/or patient convenience. Since its inception, POZEN has focused its efforts primarily on the development of pharmaceutical products for the treatment of acute and chronic pain, migraine, and other pain-related conditions. POZEN has a development and commercialization alliance with GlaxoSmithKline.

   Company:                POZEN Inc.

   Headquarters Address:   1414 Raleigh Rd.
                           Suite 400
                           Chapel Hill, NC 27517

   Main Telephone:         919-913-1030


   Ticker:                 POZN(NASDAQ)

   Type of Organization:   Public

   Industry:               Health: Biotechnology

   Key Executives:         CEO: John R. Plachetka
                           CFO: William L. Hodges

   Investor Relations
     Contact:              Fran Barsky
     Phone:                919-913-1030


Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.